Why One Drug Company Held Back a Better Drug

U.S. health officials linked six more states to what’s now the largest outbreak of cyclospora in American history — an outbreak that has contributed to at least two deaths, sickened thousands of people and left the rest of us increasingly scared of salad. Today, Christina Jewett ...  Show more

The United States is undergoing one of the biggest changes to its social safety net in recent history, with huge numbers of people getting dropped from the government’s food assistance program. Nowhere has this been more dramatic than in Arizona. Jason DeParle, who covers poverty ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...